Improvements in Severe Acute Respiratory Syndrome Coronavirus 2 Testing Cascade in the United States: Data From Serial Cross-sectional Assessments.
Improvements in Severe Acute Respiratory Syndrome Coronavirus 2 Testing Cascade in the United States: Data From Serial Cross-sectional Assessments.
复制标题
DOI：
10.1093/cid/ciab683
复制
发表时间：
2022-05-03
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
严重急性呼吸综合征冠状病毒2（SARS-CoV-2）检测对于监测病例数、早期发现和遏制感染、临床管理和监测变异至关重要。然而，缺乏关于获得、接受和检测障碍的社区数据。我们于2020年7月至2021年2月进行了一系列横断面在线调查，涵盖人口统计学、冠状病毒疾病2019症状和SARS-CoV-2诊断检测相关经验，以表征美国10个州（加州、佛罗里达、伊利诺伊州、马里兰州、马萨诸塞州、内布拉斯加州、北达科他州、南达科他州、德克萨斯州和威斯康星州）的SARS-CoV-2检测级联和相关障碍。2021年2月，在美国10个州，895名受访者（11%）表示希望在前两周内进行诊断测试，其中63%接受了测试，各州之间的差异有限。几乎所有接受检测的人（97%）都收到了结果; 56%的人在2天内收到了结果。在马里兰州、佛罗里达和伊利诺伊州，有4个时间点的连续数据可用，2021年2月，56%的人在他们想要或需要检测的同一天进行了检测，而2020年7月的这一比例为28%，45%的人在同一天收到了结果，而2020年7月的这一比例为17%。在年轻的非白人受访者和有症状或暴露史的参与者中，想要进行测试的情况更为普遍。物流方面的挑战，包括不知道去哪里，是最常提到的障碍。美国各州在获得和周转时间方面有了显着改善，但各州之间的检测障碍仍然一致，这突出了即使在大规模疫苗接种运动中继续关注检测的重要性。我们测量了2020年7月至2021年2月美国10个州的SARS-CoV-2测试经验。在获得检测的机会和周转时间方面有了显著改善，但也存在持续的障碍，突出表明在其他努力中需要继续注重检测。
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing is critical for monitoring case counts, early detection and containment of infection, clinical management, and surveillance of variants. However, community-based data on the access, uptake, and barriers to testing have been lacking. We conducted serial cross-sectional online surveys covering demographics, coronavirus disease 2019 symptoms, and experiences around SARS-CoV-2 diagnostic testing to characterize the SARS-CoV-2 testing cascade and associated barriers across 10 US states (California, Florida, Illinois, Maryland, Massachusetts, Nebraska, North Dakota, South Dakota, Texas, and Wisconsin), from July 2020 to February 2021. In February 2021, across 10 US states, 895 respondents (11%) reported wanting a diagnostic test in the prior 2 weeks, 63% of whom were tested, with limited variability across states. Almost all (97%) who were tested received their results; 56% received their results within 2 days. In Maryland, Florida, and Illinois, where serial data were available at 4 time points, 56% were tested the same day they wanted or needed a test in February 2021, compared with 28% in July 2020, and 45% received results the same day, compared with 17% in July 2020. Wanting a test was significantly more common among younger, nonwhite respondents and participants with a history of symptoms or exposure. Logistical challenges, including not knowing where to go, were the most frequently cited barriers. There were significant improvements in access and turnaround times across US states, yet barriers to testing remained consistent across states, underscoring the importance of a continued focus on testing, even amidst mass vaccination campaigns. We measured experiences around SARS-CoV-2 testing across 10 US states July 2020 – February 2021. There were significant improvements in access to testing and turnaround times, but also consistent barriers highlighting the need for continued focus on testing amidst other efforts.
登录
查看更多内容
影响因子：
4.5
作者：
Holden TM;Richardson RAK;Arevalo P;Duffus WA;Runge M;Whitney E;Wise L;Ezike NO;Patrick S;Cobey S;Gerardin J
通讯作者：
Gerardin J
DOI：
10.1056/nejmoa2033700
发表时间：
2021-02-18
期刊：
The New England journal of medicine
影响因子：
--
作者：
Libster R;Pérez Marc G;Wappner D;Coviello S;Bianchi A;Braem V;Esteban I;Caballero MT;Wood C;Berrueta M;Rondan A;Lescano G;Cruz P;Ritou Y;Fernández Viña V;Álvarez Paggi D;Esperante S;Ferreti A;Ofman G;Ciganda Á;Rodriguez R;Lantos J;Valentini R;Itcovici N;Hintze A;Oyarvide ML;Etchegaray C;Neira A;Name I;Alfonso J;López Castelo R;Caruso G;Rapelius S;Alvez F;Etchenique F;Dimase F;Alvarez D;Aranda SS;Sánchez Yanotti C;De Luca J;Jares Baglivo S;Laudanno S;Nowogrodzki F;Larrea R;Silveyra M;Leberzstein G;Debonis A;Molinos J;González M;Perez E;Kreplak N;Pastor Argüello S;Gibbons L;Althabe F;Bergel E;Polack FP;Fundación INFANT–COVID-19 Group
通讯作者：
Fundación INFANT–COVID-19 Group
影响因子：
158.5
作者：
Tromberg, Bruce J.;Schwetz, Tara A.;Collins, Francis S.
通讯作者：
Collins, Francis S.
影响因子：
39
作者：
Cheng, Hao-Yuan;Jian, Shu-Wan;Lin, Hsien-Ho
通讯作者：
Lin, Hsien-Ho
DOI：
10.1056/nejmoa2108163
发表时间：
2021-12-02
期刊：
The New England journal of medicine
影响因子：
--
作者：
Weinreich DM;Sivapalasingam S;Norton T;Ali S;Gao H;Bhore R;Xiao J;Hooper AT;Hamilton JD;Musser BJ;Rofail D;Hussein M;Im J;Atmodjo DY;Perry C;Pan C;Mahmood A;Hosain R;Davis JD;Turner KC;Baum A;Kyratsous CA;Kim Y;Cook A;Kampman W;Roque-Guerrero L;Acloque G;Aazami H;Cannon K;Simón-Campos JA;Bocchini JA;Kowal B;DiCioccio AT;Soo Y;Geba GP;Stahl N;Lipsich L;Braunstein N;Herman G;Yancopoulos GD;Trial Investigators
通讯作者：
Trial Investigators